Econ Financial Services’s Filana Therapeutics FLNA Stock Holding History

Econ Financial Services’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-73	Closed	-$3K	–	138
2022 Q1	$3K	Hold	73	–	–	﹤0.01%	134
2021 Q4	$3K	Buy	+73	New	+$3.83K	﹤0.01%	170

Other funds holding FLNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Econ Financial Services's FLNA Position: Q2 2022 in Review

Econ Financial Services sold out of Filana Therapeutics (FLNA) in Q2 2022, closing a stake of 73 shares — an estimated $3K sold.

Econ Financial Services first reported a position in FLNA in Q4 2021 and held it in 2 quarters. The position peaked at $3K in Q1 2022. 149 funds tracked by Wall St. Rank hold FLNA as of Q2 2022.

Econ Financial Services reported no remaining Filana Therapeutics position as of Q2 2022 after selling out during the quarter.
Econ Financial Services sold 73 Filana Therapeutics shares in Q2 2022, an estimated $3K.
Econ Financial Services first reported a position in Filana Therapeutics in Q4 2021 and held it in 2 quarters.
Econ Financial Services's Filana Therapeutics position peaked at $3K in Q1 2022.
149 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2022.

Based on Econ Financial Services's 13F filing for Q2 2022, filed 19 Jul 2022.